Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

BIOBANKING TRENDS, CHALLENGES, AND OPPORTUNITIES

8/20/2010

Donat Elsener, Founder, Innoco GmbH, and Director of Business Development, Hamilton Storage Technologies

Biobanking increasingly is seen as an essential tool in translating biomedical research into real improvements in healthcare. Broadly speaking, a biobank (or biorespository) is defined as a collection of tissue samples and is, potentially at least, a rich source of both genetic and clinical data.


 A relatively new field with promising expectations, biobanking presents a host of opportunities and challenges. During this week’s podcast Donat Elsener, a biobanking expert, takes a close look at these and other aspects concerning biobanks. He also talks about what kinds of institutions are developing biobanks and why they are doing so. In addition, Elsener describes the types of samples being held in biobanks and the storage limitations of those samples.


 Elsener discusses the kinds of technology and equipment that are required to establish a large biobank and gives some examples of several successful large biobanks that are up and running. 

Donat Elsener is the founder of Innoco GmbH, a Switzerland-based consulting firm. In addition, Elsenser serves as director of business development for Hamilton Storage Technologies. Biobanking and lab automation are among his fields of expertise.


Related content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

GEN Articles

MORE RELATED GEN ARTICLES

GEN Podcasts

MORE RELATED GEN PODCASTS

New Products

MORE RELATED NEW PRODUCTS

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »